Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.09 trillion and total revenue of $110 billion.
Market Cap
1.09T
Revenue
110B
Profits
-41.86B
PE Ratio
n/a
Profit Margin
-38.05%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.73B | -2.68% | 569,042 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.42B | -2.61% | 202,997 | 14.34B |
| 3 | ARGX | argenx SE | 44.80B | -2.63% | 190,546 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.15B | -3.16% | 364,972 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 31.83B | -4.03% | 141,431 | 5.34B |
| 6 | INSM | Insmed Incorporated | 29.85B | -0.66% | 796,774 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 26.50B | -1.61% | 1,461,002 | 2.38B |
| 8 | MRNA | Moderna, Inc. | 21.43B | -3.04% | 3,040,510 | 1.94B |
| 9 | BNTX | BioNTech SE | 21.31B | -2.25% | 1,282,224 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.59B | -2.74% | 1,446,609 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 19.13B | -3.08% | 858,896 | - |
| 12 | INCY | Incyte Corporation | 18.34B | -2.63% | 678,007 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.72B | -2.78% | 1,000,767 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.08B | 0.82% | 483,108 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.33B | -3.66% | 701,631 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.06B | -3.30% | 663,367 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.00B | -2.87% | 865,180 | 943.71M |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.48B | -1.01% | 659,190 | 3.22B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.17B | -2.12% | 244,111 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 10.61B | -2.18% | 665,823 | 2.32B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.93B | 0.28% | 102,278 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 8.67B | 5.16% | 1,999,536 | 6.23M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.24B | -0.33% | 170,973 | 7.46M |
| 24 | IBRX | ImmunityBio, Inc. | 8.17B | -3.87% | 8,758,770 | 113.29M |
| 25 | PCVX | Vaxcyte, Inc. | 8.13B | -1.86% | 343,911 | - |
| 26 | AXSM | Axsome Therapeutics, Inc. | 7.91B | -3.03% | 376,703 | 638.50M |
| 27 | TECH | Bio-Techne Corporation | 7.86B | -6.34% | 1,501,231 | 1.22B |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.77B | -4.44% | 1,362,377 | 1.09B |
| 29 | NUVL | Nuvalent, Inc. | 7.69B | -2.26% | 280,586 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.60B | -3.17% | 695,148 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 7.39B | -5.64% | 774,805 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.24B | -2.85% | 70,932 | 389.13M |
| 33 | BLTE | Belite Bio, Inc | 6.71B | -1.77% | 151,068 | - |
| 34 | ACLX | Arcellx, Inc. | 6.71B | -0.01% | 833,570 | 22.29M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.38B | -4.13% | 242,115 | 39.21M |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.15B | 0.10% | 219,341 | 189.76M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.06B | -1.53% | 351,714 | 46.02M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.54B | -4.71% | 724,890 | - |
| 39 | MIRM | Mirum Pharmaceuticals, Inc. | 5.39B | -2.57% | 613,439 | 521.31M |
| 40 | XENE | Xenon Pharmaceuticals Inc. | 5.36B | -3.13% | 1,221,315 | 7.50M |
| 41 | CGON | CG Oncology, Inc. | 5.21B | -4.61% | 1,012,533 | 4.04M |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.16B | -5.15% | 350,791 | 1.73B |
| 43 | CELC | Celcuity Inc. | 5.10B | -4.77% | 557,541 | - |
| 44 | IMVT | Immunovant, Inc. | 5.08B | -2.27% | 311,947 | - |
| 45 | APGE | Apogee Therapeutics, Inc. | 4.99B | -2.87% | 245,586 | - |
| 46 | CAI | Caris Life Sciences, Inc. | 4.98B | -5.42% | 948,923 | 812.03M |
| 47 | TERN | Terns Pharmaceuticals, Inc. | 4.87B | -4.32% | 1,143,246 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.81B | -2.94% | 360,808 | - |
| 49 | CRSP | CRISPR Therapeutics AG | 4.67B | -2.52% | 1,767,706 | 3.51M |
| 50 | ERAS | Erasca, Inc. | 4.59B | -4.26% | 3,163,306 | - |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.51B | 0.03% | 1,010,445 | 634.21M |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 4.23B | -4.85% | 730,228 | 2.04M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.13B | -6.40% | 240,720 | 268.09M |
| 54 | VKTX | Viking Therapeutics, Inc. | 4.07B | -1.51% | 1,062,971 | - |
| 55 | CNTA | Centessa Pharmaceuticals plc | 3.98B | -3.40% | 439,103 | 15.00M |
| 56 | TGTX | TG Therapeutics, Inc. | 3.96B | -4.31% | 751,540 | 616.29M |
| 57 | GPCR | Structure Therapeutics Inc. | 3.91B | -5.09% | 215,225 | - |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.78B | -2.27% | 311,805 | 7.70M |
| 59 | ADMA | ADMA Biologics, Inc. | 3.68B | -1.28% | 772,158 | 510.17M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.63B | -3.19% | 382,917 | 1.07B |
| 61 | LEGN | Legend Biotech Corporation | 3.58B | -4.44% | 552,601 | 1.03B |
| 62 | CORT | Corcept Therapeutics Incorporated | 3.47B | -3.35% | 431,117 | 761.41M |
| 63 | NAMS | NewAmsterdam Pharma Company N.V. | 3.47B | -3.78% | 243,582 | 22.50M |
| 64 | DNLI | Denali Therapeutics Inc. | 3.25B | -5.23% | 636,420 | - |
| 65 | EWTX | Edgewise Therapeutics, Inc. | 3.23B | -2.87% | 455,093 | - |
| 66 | ALMS | Alumis Inc. | 3.16B | -3.64% | 596,365 | 22.12M |
| 67 | SYRE | Spyre Therapeutics, Inc. | 3.16B | -3.04% | 309,324 | - |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.13B | -5.00% | 971,567 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 2.91B | -2.12% | 138,876 | 451.36M |
| 70 | RCUS | Arcus Biosciences, Inc. | 2.90B | -5.41% | 302,669 | 247.00M |
| 71 | VERA | Vera Therapeutics, Inc. | 2.89B | -3.51% | 400,075 | - |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 2.89B | -3.49% | 172,624 | 218.71M |
| 73 | VRDN | Viridian Therapeutics, Inc. | 2.88B | -1.40% | 434,926 | 70.85M |
| 74 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.88B | -3.42% | 407,543 | 588.99M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.83B | -4.68% | 363,660 | 376.07M |
| 76 | TLX | Telix Pharmaceuticals Limited | 2.72B | 2.59% | 92,770 | 803.79M |
| 77 | BEAM | Beam Therapeutics Inc. | 2.53B | -2.34% | 1,034,660 | 139.74M |
| 78 | TVTX | Travere Therapeutics, Inc. | 2.51B | -4.60% | 245,735 | 490.73M |
| 79 | WVE | Wave Life Sciences Ltd. | 2.49B | -6.04% | 967,940 | 42.73M |
| 80 | TNGX | Tango Therapeutics, Inc. | 2.42B | -0.18% | 1,136,087 | 62.38M |
| 81 | MAZE | Maze Therapeutics, Inc. | 2.42B | -0.38% | 195,037 | 2.50M |
| 82 | APLS | Apellis Pharmaceuticals, Inc. | 2.37B | -4.39% | 1,094,212 | 1.00B |
| 83 | IRON | Disc Medicine, Inc. | 2.32B | -4.62% | 167,611 | - |
| 84 | IMNM | Immunome, Inc. | 2.32B | -4.32% | 367,273 | 6.94M |
| 85 | AAPG | Ascentage Pharma Group International | 2.22B | -0.37% | 304 | 54.52M |
| 86 | DAWN | Day One Biopharmaceuticals, Inc. | 2.20B | 0.07% | 5,639,504 | 158.18M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.16B | -2.43% | 477,591 | - |
| 88 | SNDX | Syndax Pharmaceuticals, Inc. | 2.15B | -0.49% | 898,662 | 172.35M |
| 89 | GLPG | Galapagos NV | 2.14B | -1.81% | 156,796 | 1.31B |
| 90 | ZLAB | Zai Lab Limited | 2.09B | -2.20% | 182,202 | 460.16M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.07B | -3.33% | 487,301 | 673.00M |
| 92 | STOK | Stoke Therapeutics, Inc. | 2.06B | -4.93% | 215,575 | 205.63M |
| 93 | MANE | Veradermics, Incorporated | 2.03B | 6.51% | 167,456 | - |
| 94 | CLDX | Celldex Therapeutics, Inc. | 1.98B | -4.84% | 208,320 | 1.55M |
| 95 | MESO | Mesoblast Limited | 1.98B | -3.26% | 51,743 | 65.38M |
| 96 | NKTR | Nektar Therapeutics | 1.96B | -4.57% | 364,133 | 62.60M |
| 97 | OCUL | Ocular Therapeutix, Inc. | 1.95B | -5.89% | 3,145,130 | 51.95M |
| 98 | ADPT | Adaptive Biotechnologies Corporation | 1.92B | -12.24% | 1,483,181 | 276.98M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.91B | -2.84% | 261,227 | 283.06M |
| 100 | SLNO | Soleno Therapeutics, Inc. | 1.91B | -5.22% | 883,493 | 190.41M |
| 101 | TYRA | Tyra Biosciences, Inc. | 1.89B | -4.16% | 401,151 | - |
| 102 | RLAY | Relay Therapeutics, Inc. | 1.87B | -3.33% | 1,073,787 | 15.36M |
| 103 | ANAB | AnaptysBio, Inc. | 1.82B | -2.37% | 247,643 | 234.60M |
| 104 | PVLA | Palvella Therapeutics, Inc. | 1.80B | -4.26% | 101,250 | - |
| 105 | SRPT | Sarepta Therapeutics, Inc. | 1.78B | -3.39% | 1,025,786 | 2.20B |
| 106 | DFTX | Definium Therapeutics, Inc. | 1.78B | -4.40% | 776,451 | - |
| 107 | ELVN | Enliven Therapeutics, Inc. | 1.77B | -3.83% | 275,641 | - |
| 108 | ZYME | Zymeworks Inc. | 1.75B | -5.37% | 316,694 | 105.97M |
| 109 | IOVA | Iovance Biotherapeutics, Inc. | 1.73B | -13.02% | 14,652,145 | 263.50M |
| 110 | PHVS | Pharvaris N.V. | 1.72B | -3.32% | 61,584 | - |
| 111 | CAPR | Capricor Therapeutics, Inc. | 1.72B | -1.01% | 536,735 | 11.13M |
| 112 | RXRX | Recursion Pharmaceuticals, Inc. | 1.72B | -5.80% | 9,924,969 | 74.68M |
| 113 | NVAX | Novavax, Inc. | 1.70B | -3.33% | 1,873,015 | 1.12B |
| 114 | SION | Sionna Therapeutics, Inc. | 1.66B | -3.65% | 88,989 | - |
| 115 | INVA | Innoviva, Inc. | 1.65B | -0.76% | 127,538 | 411.33M |
| 116 | GENB | Generate Biomedicines, Inc. | 1.64B | 1.42% | 313,048 | 31.89M |
| 117 | NBTX | Nanobiotix S.A. | 1.63B | -3.87% | 20,558 | 11.93M |
| 118 | VCEL | Vericel Corporation | 1.62B | -3.04% | 202,165 | 276.26M |
| 119 | HRMY | Harmony Biosciences Holdings, Inc. | 1.61B | -3.44% | 171,844 | 868.45M |
| 120 | AGIO | Agios Pharmaceuticals, Inc. | 1.61B | -2.39% | 176,578 | 54.03M |
| 121 | IMCR | Immunocore Holdings plc | 1.60B | -2.95% | 62,371 | 400.02M |
| 122 | OCS | Oculis Holding AG | 1.60B | -0.59% | 137,301 | 1.51M |
| 123 | ORKA | Oruka Therapeutics, Inc. | 1.59B | -4.62% | 192,703 | - |
| 124 | NRIX | Nurix Therapeutics, Inc. | 1.57B | -4.48% | 372,203 | 83.98M |
| 125 | BHVN | Biohaven Ltd. | 1.50B | -4.40% | 751,060 | - |
| 126 | VIR | Vir Biotechnology, Inc. | 1.50B | -4.28% | 1,365,397 | 68.56M |
| 127 | NTLA | Intellia Therapeutics, Inc. | 1.50B | -2.31% | 1,796,344 | 67.67M |
| 128 | NUVB | Nuvation Bio Inc. | 1.50B | -4.79% | 1,946,370 | 62.90M |
| 129 | KOD | Kodiak Sciences Inc. | 1.49B | -2.20% | 379,048 | - |
| 130 | ARDX | Ardelyx, Inc. | 1.41B | -4.34% | 972,846 | 407.32M |
| 131 | ATAI | AtaiBeckley Inc. | 1.40B | -5.17% | 1,633,277 | 4.09M |
| 132 | TRVI | Trevi Therapeutics, Inc. | 1.40B | -8.29% | 468,458 | - |
| 133 | RAPP | Rapport Therapeutics, Inc. | 1.36B | -6.58% | 136,868 | - |
| 134 | CRVS | Corvus Pharmaceuticals, Inc. | 1.34B | -5.33% | 652,719 | - |
| 135 | ZBIO | Zenas BioPharma, Inc. | 1.32B | -2.64% | 149,512 | 15.00M |
| 136 | SVRA | Savara Inc. | 1.29B | -5.42% | 435,977 | - |
| 137 | IMTX | Immatics N.V. | 1.27B | -5.28% | 141,752 | 56.67M |
| 138 | MBX | MBX Biosciences, Inc. | 1.27B | -7.19% | 365,108 | - |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.26B | -2.51% | 167,202 | - |
| 140 | DBVT | DBV Technologies S.A. | 1.25B | -2.56% | 279,943 | 5.50M |
| 141 | GLUE | Monte Rosa Therapeutics, Inc. | 1.25B | -7.62% | 319,517 | 181.54M |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.23B | -0.33% | 1,734,855 | 6.31M |
| 143 | IVA | Inventiva S.A. | 1.23B | -6.64% | 116,880 | 19.93M |
| 144 | MLTX | MoonLake Immunotherapeutics | 1.23B | -4.15% | 355,463 | - |
| 145 | PGEN | Precigen, Inc. | 1.19B | -2.05% | 675,547 | 6.31M |
| 146 | ORIC | ORIC Pharmaceuticals, Inc. | 1.18B | -6.59% | 821,390 | - |
| 147 | SEPN | Septerna, Inc. | 1.18B | -0.15% | 132,386 | 45.95M |
| 148 | OLMA | Olema Pharmaceuticals, Inc. | 1.17B | -4.42% | 803,080 | - |
| 149 | EYPT | EyePoint, Inc. | 1.16B | -6.50% | 914,713 | 31.37M |
| 150 | QURE | uniQure N.V. | 1.10B | 0.17% | 1,044,046 | 16.10M |
| 151 | PHAR | Pharming Group N.V. | 1.09B | -2.33% | 10,147 | 376.13M |
| 152 | ABCL | AbCellera Biologics Inc. | 1.05B | -5.48% | 1,324,128 | 75.13M |
| 153 | AVBP | ArriVent BioPharma, Inc. | 1.04B | -4.51% | 174,306 | - |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.04B | -2.93% | 79,317 | 1.40M |
| 155 | GERN | Geron Corporation | 1.01B | -4.82% | 18,535,750 | 183.88M |
| 156 | AKTS | Aktis Oncology, Inc. | 992.15M | -2.68% | 134,660 | 5.56M |
| 157 | GHRS | GH Research PLC | 965.80M | 2.91% | 295,907 | - |
| 158 | VALN | Valneva SE | 961.97M | -6.51% | 8,148 | 211.09M |
| 159 | CMPX | Compass Therapeutics, Inc. | 943.66M | -6.26% | 538,391 | 850.00K |
| 160 | XERS | Xeris Biopharma Holdings, Inc. | 936.30M | -5.24% | 868,132 | 291.85M |
| 161 | URGN | UroGen Pharma Ltd. | 906.95M | -1.11% | 266,531 | 109.79M |
| 162 | SGP | SpyGlass Pharma, Inc. | 889.91M | -1.44% | 41,514 | - |
| 163 | MRVI | Maravai LifeSciences Holdings, Inc. | 883.03M | -3.24% | 581,007 | 185.74M |
| 164 | KALV | KalVista Pharmaceuticals, Inc. | 876.47M | -4.93% | 404,760 | 1.43M |
| 165 | FTRE | Fortrea Holdings Inc. | 861.14M | -2.23% | 538,090 | 2.72B |
| 166 | SLS | SELLAS Life Sciences Group, Inc. | 856.52M | -8.21% | 5,258,834 | - |
| 167 | MNKD | MannKind Corporation | 853.44M | -1.77% | 2,762,595 | 348.97M |
| 168 | JANX | Janux Therapeutics, Inc. | 850.12M | -0.75% | 323,355 | 10.00M |
| 169 | CGEM | Cullinan Therapeutics, Inc. | 848.58M | -2.03% | 270,517 | - |
| 170 | ABUS | Arbutus Biopharma Corporation | 845.26M | -6.89% | 2,502,660 | 14.61M |
| 171 | XNCR | Xencor, Inc. | 835.69M | -5.36% | 444,692 | 125.58M |
| 172 | EVMN | Evommune, Inc. | 833.10M | -1.15% | 97,129 | 13.00M |
| 173 | SPRY | ARS Pharmaceuticals, Inc. | 823.67M | -1.01% | 953,741 | 84.28M |
| 174 | MPLT | MapLight Therapeutics, Inc. | 822.20M | -0.74% | 51,853 | - |
| 175 | ANNX | Annexon, Inc. | 819.06M | -8.87% | 1,462,103 | - |
| 176 | PHAT | Phathom Pharmaceuticals, Inc. | 817.93M | -6.86% | 588,029 | 175.11M |
| 177 | OMER | Omeros Corporation | 814.65M | -3.69% | 381,923 | - |
| 178 | SANA | Sana Biotechnology, Inc. | 811.28M | -3.49% | 1,542,980 | - |
| 179 | CTMX | CytomX Therapeutics, Inc. | 804.82M | -2.66% | 1,059,601 | 113.63M |
| 180 | KURA | Kura Oncology, Inc. | 802.03M | -1.52% | 696,718 | 67.48M |
| 181 | ARVN | Arvinas, Inc. | 793.12M | -8.01% | 320,999 | 262.60M |
| 182 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 765.11M | -4.30% | 90,523 | - |
| 183 | OCGN | Ocugen, Inc. | 757.44M | 0.43% | 8,510,976 | 4.41M |
| 184 | DRUG | Bright Minds Biosciences Inc. | 734.07M | -6.30% | 98,508 | - |
| 185 | TENX | Tenax Therapeutics, Inc. | 732.37M | -0.41% | 206,029 | - |
| 186 | GYRE | Gyre Therapeutics, Inc. | 726.21M | -4.08% | 147,327 | 116.59M |
| 187 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.78M | -2.33% | 752,325 | 49.80M |
| 188 | PROK | ProKidney Corp. | 700.94M | -5.28% | 257,569 | 744.00K |
| 189 | TBPH | Theravance Biopharma, Inc. | 696.75M | -0.43% | 219,534 | 80.33M |
| 190 | ANRO | Alto Neuroscience, Inc. | 689.98M | -3.64% | 156,082 | - |
| 191 | JBIO | Jade Biosciences, Inc. | 689.93M | -0.21% | 108,337 | - |
| 192 | EIKN | Eikon Therapeutics, Inc. | 662.93M | -6.83% | 203,749 | - |
| 193 | AGMB | AgomAb Therapeutics NV | 662.33M | 0.15% | 14,573 | - |
| 194 | MDXG | MiMedx Group, Inc. | 659.64M | -2.63% | 219,835 | 418.63M |
| 195 | PRME | Prime Medicine, Inc. | 655.19M | -3.39% | 1,291,425 | 4.63M |
| 196 | ZURA | Zura Bio Limited | 639.46M | -3.58% | 168,441 | - |
| 197 | TECX | Tectonic Therapeutic, Inc. | 633.34M | -3.05% | 126,008 | - |
| 198 | LBRX | LB Pharmaceuticals Inc | 628.68M | 0.69% | 140,703 | - |
| 199 | DRTS | Alpha Tau Medical Ltd. | 623.99M | 0.71% | 124,106 | - |
| 200 | DSGN | Design Therapeutics, Inc. | 620.73M | 0.55% | 153,570 | - |
| 201 | REPL | Replimune Group, Inc. | 620.12M | -4.94% | 499,047 | - |
| 202 | MGTX | MeiraGTx Holdings plc | 611.73M | -2.69% | 126,038 | 27.42M |
| 203 | SLDB | Solid Biosciences Inc. | 599.91M | -0.19% | 727,259 | - |
| 204 | VOR | Vor Biopharma Inc. | 596.64M | -3.43% | 282,361 | - |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 586.53M | -4.03% | 764,064 | 106.47M |
| 206 | ADCT | ADC Therapeutics SA | 564.08M | -9.02% | 391,929 | 81.36M |
| 207 | VNDA | Vanda Pharmaceuticals Inc. | 556.21M | 1.29% | 877,084 | 216.11M |
| 208 | ALLO | Allogene Therapeutics, Inc. | 552.84M | -6.46% | 2,030,688 | 22.00K |
| 209 | NMRA | Neumora Therapeutics, Inc. | 551.45M | -3.85% | 390,430 | - |
| 210 | IMMX | Immix Biopharma, Inc. | 545.40M | -1.05% | 325,755 | - |
| 211 | LRMR | Larimar Therapeutics, Inc. | 537.52M | -8.67% | 1,299,111 | - |
| 212 | YDES | YD Bio Limited | 530.21M | -2.14% | 4,314 | 510.36K |
| 213 | VSTM | Verastem, Inc. | 527.01M | -3.07% | 987,466 | 30.91M |
| 214 | RCKT | Rocket Pharmaceuticals, Inc. | 525.47M | -2.42% | 837,859 | - |
| 215 | CTNM | Contineum Therapeutics, Inc. | 523.45M | -6.41% | 88,506 | - |
| 216 | IVVD | Invivyd, Inc. | 517.15M | -3.68% | 636,352 | 53.43M |
| 217 | LYEL | Lyell Immunopharma, Inc. | 513.04M | -3.94% | 41,226 | 41.00K |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 511.88M | 1.93% | 194,761 | - |
| 219 | CRMD | CorMedix Inc. | 500.39M | -5.38% | 604,440 | 311.71M |
| 220 | RIGL | Rigel Pharmaceuticals, Inc. | 500.07M | -0.66% | 158,875 | 294.28M |
| 221 | FULC | Fulcrum Therapeutics, Inc. | 499.50M | -3.72% | 299,611 | 80.00M |
| 222 | UPB | Upstream Bio, Inc. | 496.61M | -1.82% | 469,849 | 2.80M |
| 223 | PRTA | Prothena Corporation plc | 496.34M | -3.76% | 237,206 | 9.68M |
| 224 | ENGN | enGene Holdings Inc. | 491.37M | 6.61% | 1,397,147 | - |
| 225 | AVIR | Atea Pharmaceuticals, Inc. | 483.61M | -0.49% | 300,631 | - |
| 226 | LXEO | Lexeo Therapeutics, Inc. | 476.61M | -4.67% | 203,857 | - |
| 227 | FBRX | Forte Biosciences, Inc. | 475.56M | -2.59% | 45,310 | - |
| 228 | ALT | Altimmune, Inc. | 472.15M | -4.47% | 1,540,411 | 41.00K |
| 229 | ACRS | Aclaris Therapeutics, Inc. | 468.53M | -2.36% | 476,566 | 7.83M |
| 230 | RGNX | REGENXBIO Inc. | 468.13M | -3.30% | 287,772 | 170.44M |
| 231 | EPRX | Eupraxia Pharmaceuticals Inc. | 460.69M | -0.46% | 50,602 | - |
| 232 | TRDA | Entrada Therapeutics, Inc. | 459.36M | -5.48% | 84,170 | 25.42M |
| 233 | IPSC | Century Therapeutics, Inc. | 458.10M | -6.59% | 960,845 | 109.16M |
| 234 | RLMD | Relmada Therapeutics, Inc. | 452.47M | -2.37% | 867,609 | - |
| 235 | ASMB | Assembly Biosciences, Inc. | 451.90M | -2.19% | 28,039 | 37.19M |
| 236 | FDMT | 4D Molecular Therapeutics, Inc. | 430.00M | -1.29% | 166,008 | 120.00K |
| 237 | VTVT | vTv Therapeutics Inc. | 424.69M | -2.49% | 100,185 | 17.00K |
| 238 | AVXL | Anavex Life Sciences Corp. | 423.05M | -1.83% | 443,061 | - |
| 239 | PEPG | PepGen Inc. | 421.95M | -2.94% | 196,572 | - |
| 240 | BNTC | Benitec Biopharma Inc. | 419.97M | -0.16% | 215,362 | - |
| 241 | STRO | Sutro Biopharma, Inc. | 412.15M | 2.49% | 123,802 | 105.65M |
| 242 | STTK | Shattuck Labs, Inc. | 409.35M | -2.72% | 164,592 | 1.00M |
| 243 | IMMP | Immutep Limited | 408.45M | 1.10% | 113,624 | 5.28M |
| 244 | PRTC | PureTech Health plc | 405.78M | -1.45% | 1,645 | 6.39M |
| 245 | LCTX | Lineage Cell Therapeutics, Inc. | 402.28M | -3.87% | 986,980 | 14.56M |
| 246 | DMAC | DiaMedica Therapeutics Inc. | 400.23M | -3.24% | 99,367 | - |
| 247 | CBIO | Crescent Biopharma, Inc. | 399.56M | 1.26% | 73,007 | 10.84M |
| 248 | NAGE | Niagen Bioscience, Inc. | 394.82M | 0.61% | 477,102 | 129.42M |
| 249 | AUTL | Autolus Therapeutics plc | 392.56M | -5.45% | 666,160 | 51.13M |
| 250 | ARMP | Armata Pharmaceuticals, Inc. | 391.01M | -6.61% | 9,942 | 5.05M |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 389.58M | -5.26% | 44,209 | 66.98M |
| 252 | MNPR | Monopar Therapeutics Inc. | 379.34M | -0.41% | 56,448 | - |
| 253 | GLSI | Greenwich LifeSciences, Inc. | 374.07M | 1.62% | 77,726 | - |
| 254 | DNA | Ginkgo Bioworks Holdings, Inc. | 366.71M | -7.76% | 888,354 | 170.16M |
| 255 | AURA | Aura Biosciences, Inc. | 365.14M | 1.41% | 133,965 | - |
| 256 | SLN | Silence Therapeutics plc | 364.65M | 10.60% | 106,206 | 559.00K |
| 257 | CADL | Candel Therapeutics, Inc. | 362.57M | -2.94% | 676,986 | - |
| 258 | IMRX | Immuneering Corporation | 360.12M | -1.42% | 248,339 | - |
| 259 | LENZ | LENZ Therapeutics, Inc. | 358.90M | -4.58% | 246,273 | 17.50M |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 356.74M | -5.77% | 152,330 | 33.98M |
| 261 | BCYC | Bicycle Therapeutics plc | 350.31M | -3.81% | 116,379 | 28.34M |
| 262 | NGNE | Neurogene Inc. | 345.04M | -3.28% | 32,534 | 925.00K |
| 263 | CLYM | Climb Bio, Inc. | 341.54M | -2.46% | 244,337 | - |
| 264 | NBP | NovaBridge Biosciences | 341.26M | -8.07% | 373,922 | - |
| 265 | ABSI | Absci Corporation | 339.84M | -7.76% | 1,961,107 | 2.82M |
| 266 | IRD | Opus Genetics, Inc. | 337.59M | -3.59% | 688,663 | 14.20M |
| 267 | NERV | Minerva Neurosciences, Inc. | 334.08M | 5.75% | 134,934 | - |
| 268 | XOMA | XOMA Royalty Corporation | 315.76M | -1.48% | 45,870 | 47.11M |
| 269 | CABA | Cabaletta Bio, Inc. | 315.75M | 0.31% | 938,408 | - |
| 270 | AVTX | Avalo Therapeutics, Inc. | 311.57M | -1.58% | 254,350 | 192.00K |
| 271 | ACIU | AC Immune SA | 310.68M | 2.61% | 208,645 | 5.48M |
| 272 | RZLT | Rezolute, Inc. | 309.02M | -6.45% | 593,882 | - |
| 273 | PBYI | Puma Biotechnology, Inc. | 302.21M | -1.00% | 77,911 | 228.37M |
| 274 | ANL | Adlai Nortye Ltd. | 298.15M | -8.39% | 76,378 | -1.35M |
| 275 | PALI | Palisade Bio, Inc. | 298.01M | - | 1,957,285 | - |
| 276 | NAUT | Nautilus Biotechnology, Inc. | 296.16M | -3.31% | 179,296 | - |
| 277 | VYGR | Voyager Therapeutics, Inc. | 293.23M | 1.44% | 517,095 | 40.37M |
| 278 | TARA | Protara Therapeutics, Inc. | 291.24M | -3.84% | 433,431 | - |
| 279 | CNTX | Context Therapeutics Inc. | 290.34M | -0.32% | 335,651 | - |
| 280 | PRLD | Prelude Therapeutics Incorporated | 285.92M | -8.92% | 161,195 | 12.14M |
| 281 | FHTX | Foghorn Therapeutics Inc. | 285.87M | -13.81% | 160,513 | 30.91M |
| 282 | CAMP | Camp4 Therapeutics Corporation | 282.70M | -2.77% | 104,538 | 3.50M |
| 283 | CLLS | Cellectis S.A. | 282.07M | -6.71% | 75,083 | 82.55M |
| 284 | ALDX | Aldeyra Therapeutics, Inc. | 278.65M | -6.28% | 853,852 | - |
| 285 | CCCC | C4 Therapeutics, Inc. | 277.12M | -5.02% | 1,027,854 | 35.95M |
| 286 | CBUS | Cibus, Inc. | 272.25M | -0.49% | 245,346 | 3.79M |
| 287 | OABI | OmniAb, Inc. | 270.74M | -4.35% | 118,720 | 18.67M |
| 288 | ALXO | ALX Oncology Holdings Inc. | 269.80M | -4.65% | 138,321 | - |
| 289 | IKT | Inhibikase Therapeutics, Inc. | 269.46M | -2.48% | 461,538 | 1.00 |
| 290 | ABEO | Abeona Therapeutics Inc. | 261.20M | -3.79% | 685,701 | 400.00K |
| 291 | HELP | Cybin Inc. | 261.19M | -2.97% | 321,067 | - |
| 292 | OVID | Ovid Therapeutics Inc. | 259.07M | -3.86% | 437,234 | 6.61M |
| 293 | FENC | Fennec Pharmaceuticals Inc. | 258.88M | -4.89% | 34,610 | 38.79M |
| 294 | ENLV | Enlivex Ltd. | 258.77M | -2.67% | 104,916 | - |
| 295 | ALEC | Alector, Inc. | 250.52M | -2.16% | 325,608 | 21.05M |
| 296 | EDIT | Editas Medicine, Inc. | 247.62M | -4.89% | 723,117 | 40.52M |
| 297 | OBIO | Orchestra BioMed Holdings, Inc. | 245.34M | -5.54% | 110,188 | 2.82M |
| 298 | CHRS | Coherus Oncology, Inc. | 244.32M | -8.43% | 1,417,603 | 42.17M |
| 299 | SABS | SAB Biotherapeutics, Inc. | 243.04M | 4.15% | 1,948,167 | 114.70K |
| 300 | SRZN | Surrozen, Inc. | 239.60M | -4.66% | 43,172 | 3.60M |
| 301 | NVCT | Nuvectis Pharma, Inc. | 239.42M | -3.14% | 24,171 | - |
| 302 | SLGL | Sol-Gel Technologies Ltd. | 233.85M | -10.97% | 26,014 | 18.97M |
| 303 | PLX | Protalix BioTherapeutics, Inc. | 225.98M | -2.77% | 290,534 | 61.84M |
| 304 | PLYX | Polaryx Therapeutics, Inc. | 224.88M | -17.53% | 703,127 | - |
| 305 | HUMA | Humacyte, Inc. | 224.84M | -2.10% | 2,244,346 | 1.57M |
| 306 | ACHV | Achieve Life Sciences, Inc. | 224.12M | -3.88% | 298,776 | - |
| 307 | ELDN | Eledon Pharmaceuticals, Inc. | 216.63M | -1.09% | 493,693 | - |
| 308 | CNTN | Canton Strategic Holdings, Inc. | 216.38M | -9.68% | 273,991 | - |
| 309 | RNAC | Cartesian Therapeutics, Inc. | 216.05M | -1.33% | 49,342 | 2.80M |
| 310 | MDWD | MediWound Ltd. | 214.27M | -3.14% | 24,687 | 16.96M |
| 311 | KROS | Keros Therapeutics, Inc. | 209.79M | -5.59% | 299,515 | 244.06M |
| 312 | CGEN | Compugen Ltd. | 208.49M | -3.29% | 198,968 | 72.76M |
| 313 | MGNX | MacroGenics, Inc. | 200.20M | -5.69% | 896,892 | 149.50M |
| 314 | TNYA | Tenaya Therapeutics, Inc. | 199.96M | 7.56% | 3,908,367 | - |
| 315 | GALT | Galectin Therapeutics Inc. | 199.87M | 2.99% | 359,765 | - |
| 316 | ARCT | Arcturus Therapeutics Holdings Inc. | 199.25M | -6.03% | 226,197 | 82.03M |
| 317 | ABOS | Acumen Pharmaceuticals, Inc. | 197.07M | -3.46% | 168,487 | - |
| 318 | ELTX | Elicio Therapeutics, Inc. | 195.37M | -5.17% | 39,312 | - |
| 319 | CRBU | Caribou Biosciences, Inc. | 185.54M | -2.54% | 379,188 | 11.16M |
| 320 | PRQR | ProQR Therapeutics N.V. | 184.35M | -3.31% | 141,105 | 18.86M |
| 321 | WHWK | Whitehawk Therapeutics, Inc. | 183.80M | -2.74% | 100,701 | 14.38M |
| 322 | NTHI | NeOnc Technologies Holdings, Inc. | 183.66M | -1.81% | 10,243 | 59.99K |
| 323 | IMUX | Immunic, Inc. | 180.69M | -4.48% | 2,946,242 | - |
| 324 | ZNTL | Zentalis Pharmaceuticals, Inc. | 180.01M | -6.08% | 355,752 | 26.87M |
| 325 | MOLN | Molecular Partners AG | 179.78M | -0.82% | 563 | 856.30K |
| 326 | HRTX | Heron Therapeutics, Inc. | 175.41M | -4.08% | 651,984 | 154.90M |
| 327 | PMN | ProMIS Neurosciences, Inc. | 175.07M | -2.82% | 14,116 | - |
| 328 | SGMT | Sagimet Biosciences Inc. | 174.15M | -6.71% | 110,565 | - |
| 329 | VXRT | Vaxart, Inc. | 174.13M | -5.59% | 274,835 | 148.20M |
| 330 | MIST | Milestone Pharmaceuticals Inc. | 173.20M | -0.29% | 683,367 | - |
| 331 | ARTV | Artiva Biotherapeutics, Inc. | 171.29M | -2.81% | 239,506 | 251.00K |
| 332 | TNXP | Tonix Pharmaceuticals Holding Corp. | 170.80M | -4.51% | 136,557 | 10.30M |
| 333 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 170.62M | -7.77% | 127,752 | - |
| 334 | KLRS | Kalaris Therapeutics, Inc. | 169.44M | -1.63% | 32,531 | - |
| 335 | MENS | Jyong Biotech Ltd. | 167.64M | -2.24% | 93,581 | - |
| 336 | ADAG | Adagene Inc. | 167.55M | 0.14% | 86,583 | 103.20K |
| 337 | TLSA | Tiziana Life Sciences Ltd | 163.36M | -2.29% | 60,441 | - |
| 338 | NKTX | Nkarta, Inc. | 161.24M | -6.58% | 312,867 | - |
| 339 | RANI | Rani Therapeutics Holdings, Inc. | 156.76M | -5.84% | 805,775 | 1.20M |
| 340 | CNTB | Connect Biopharma Holdings Limited | 156.35M | -7.39% | 30,922 | 762.00K |
| 341 | CDXS | Codexis, Inc. | 154.45M | 34.65% | 34,208,367 | 70.39M |
| 342 | UNCY | Unicycive Therapeutics, Inc. | 151.30M | - | 130,344 | - |
| 343 | SGMO | Sangamo Therapeutics, Inc. | 148.90M | -2.15% | 728,446 | 32.88M |
| 344 | IPHA | Innate Pharma S.A. | 146.43M | -9.68% | 24,294 | 14.84M |
| 345 | SPRO | Spero Therapeutics, Inc. | 145.07M | -0.58% | 136,054 | 40.55M |
| 346 | KPTI | Karyopharm Therapeutics Inc. | 141.98M | -11.54% | 461,764 | 146.07M |
| 347 | ANTX | AN2 Therapeutics, Inc. | 139.61M | 0.10% | 442,988 | - |
| 348 | FATE | Fate Therapeutics, Inc. | 138.35M | -3.25% | 536,148 | 6.65M |
| 349 | ORMP | Oramed Pharmaceuticals Inc. | 134.13M | -0.88% | 53,492 | 2.00M |
| 350 | EQ | Equillium, Inc. | 132.14M | 9.05% | 262,239 | 4.39M |
| 351 | CRDF | Cardiff Oncology, Inc. | 131.60M | -4.23% | 495,224 | 593.00K |
| 352 | DTIL | Precision BioSciences, Inc. | 129.51M | 6.32% | 273,472 | 698.00K |
| 353 | HURA | TuHURA Biosciences, Inc. | 125.08M | 3.00% | 711,172 | - |
| 354 | ACOG | Alpha Cognition Inc. | 125.02M | -2.54% | 4,276 | 7.43M |
| 355 | BDTX | Black Diamond Therapeutics, Inc. | 121.36M | -5.33% | 245,157 | 70.00M |
| 356 | GNLX | Genelux Corporation | 116.91M | -5.04% | 47,403 | 8.00K |
| 357 | AARD | Aardvark Therapeutics, Inc. | 115.62M | 2.12% | 144,800 | - |
| 358 | INO | Inovio Pharmaceuticals, Inc. | 115.42M | -0.59% | 446,971 | 182.34K |
| 359 | KRRO | Korro Bio, Inc. | 113.99M | -2.30% | 52,720 | 7.37M |
| 360 | COYA | Coya Therapeutics, Inc. | 110.32M | -4.56% | 108,508 | 3.99M |
| 361 | GANX | Gain Therapeutics, Inc. | 108.46M | -0.70% | 375,081 | - |
| 362 | QTTB | Q32 Bio Inc. | 107.82M | 6.66% | 185,166 | 53.74M |
| 363 | GOSS | Gossamer Bio, Inc. | 107.09M | -5.59% | 4,778,771 | 44.05M |
| 364 | TTRX | Turn Therapeutics Inc. | 106.59M | 0.98% | 8,171 | - |
| 365 | AGEN | Agenus Inc. | 104.07M | -7.55% | 263,297 | 106.83M |
| 366 | ONCY | Oncolytics Biotech Inc. | 103.49M | -4.78% | 650,916 | - |
| 367 | DWTX | Dogwood Therapeutics, Inc. | 102.22M | 9.25% | 30,411 | - |
| 368 | FBIO | Fortress Biotech, Inc. | 101.49M | 1.55% | 205,576 | 62.30M |
| 369 | BMEA | Biomea Fusion, Inc. | 100.40M | -5.33% | 540,659 | - |
| 370 | SEER | Seer, Inc. | 97.89M | -1.42% | 77,967 | 16.58M |
| 371 | VRCA | Verrica Pharmaceuticals Inc. | 97.30M | -2.80% | 101,929 | 35.58M |
| 372 | CGTX | Cognition Therapeutics, Inc. | 95.78M | -4.82% | 377,349 | - |
| 373 | ANIX | Anixa Biosciences, Inc. | 95.55M | -3.06% | 21,655 | - |
| 374 | PYXS | Pyxis Oncology, Inc. | 94.02M | -3.21% | 77,562 | 2.82M |
| 375 | CING | Cingulate Inc. | 91.68M | 3.41% | 383,645 | - |
| 376 | MAIA | MAIA Biotechnology, Inc. | 91.22M | -0.96% | 268,281 | - |
| 377 | VANI | Vivani Medical, Inc. | 89.43M | -1.76% | 226,689 | - |
| 378 | OKYO | OKYO Pharma Limited | 86.82M | -1.17% | 16,063 | - |
| 379 | IBIO | iBio, Inc. | 86.36M | 2.88% | 315,478 | 300.00K |
| 380 | ATYR | aTyr Pharma, Inc. | 85.03M | -5.93% | 761,628 | 190.00K |
| 381 | PLRX | Pliant Therapeutics, Inc. | 84.80M | 3.76% | 266,477 | - |
| 382 | PMVP | PMV Pharmaceuticals, Inc. | 84.53M | -0.94% | 67,413 | - |
| 383 | SPRB | Spruce Biosciences, Inc. | 84.50M | -4.04% | 6,868 | 697.00K |
| 384 | KZIA | Kazia Therapeutics Limited | 84.01M | -4.93% | 44,529 | 1.20M |
| 385 | PTHS | Pelthos Therapeutics Inc. | 81.94M | 8.92% | 30 | 7.41M |
| 386 | CSBR | Champions Oncology, Inc. | 81.93M | - | 613 | 58.42M |
| 387 | PYPD | PolyPid Ltd. | 79.77M | -3.91% | 12,417 | - |
| 388 | MCRB | Seres Therapeutics, Inc. | 78.98M | -2.24% | 19,388 | 351.00K |
| 389 | LONA | LeonaBio, Inc. | 71.85M | 11.37% | 32,205 | - |
| 390 | ACET | Adicet Bio, Inc. | 71.45M | -5.35% | 56,385 | - |
| 391 | XBIT | XBiotech Inc. | 70.43M | -1.28% | 8,115 | - |
| 392 | GUTS | Fractyl Health, Inc. | 69.82M | -3.16% | 840,758 | 3.00K |
| 393 | NRXS | NeurAxis, Inc. | 69.24M | 0.78% | 35,174 | 3.36M |
| 394 | COEP | Coeptis Therapeutics Holdings, Inc. | 68.27M | -3.69% | 17,319 | 501.00K |
| 395 | MNOV | MediciNova, Inc. | 67.93M | -2.82% | 14,963 | 409.66K |
| 396 | TCRX | TScan Therapeutics, Inc. | 66.86M | 2.17% | 570,634 | 10.33M |
| 397 | ANVS | Annovis Bio, Inc. | 66.79M | 0.80% | 98,380 | - |
| 398 | GRCE | Grace Therapeutics, Inc. | 66.54M | 8.86% | 1,380,609 | - |
| 399 | IMA | ImageneBio, Inc. | 66.53M | -1.00% | 10,808 | 800.00K |
| 400 | IFRX | InflaRx N.V. | 66.30M | 1.74% | 120,639 | 73.73K |
| 401 | BYSI | BeyondSpring Inc. | 65.38M | 5.30% | 17,861 | 1.88M |
| 402 | MREO | Mereo BioPharma Group plc | 63.92M | 0.68% | 539,689 | 500.00K |
| 403 | ENTX | Entera Bio Ltd. | 62.82M | -1.44% | 29,994 | 124.00K |
| 404 | ATHE | Alterity Therapeutics Limited | 62.23M | -1.08% | 1,691 | 4.43M |
| 405 | EXOZ | eXoZymes, Inc. | 61.57M | 0.41% | 859 | -700.00 |
| 406 | LPCN | Lipocine Inc. | 60.59M | -7.68% | 142,546 | 1.98M |
| 407 | MGX | Metagenomi Therapeutics, Inc. | 59.82M | -3.05% | 122,408 | 25.21M |
| 408 | HYFT | MindWalk Holdings Corp. | 59.76M | - | 844,391 | 19.02M |
| 409 | TIL | Instil Bio, Inc. | 59.00M | -3.65% | 10,330 | - |
| 410 | NRXP | NRx Pharmaceuticals, Inc. | 58.96M | 0.54% | 324,613 | 242.00K |
| 411 | ACTU | Actuate Therapeutics, Inc. | 58.34M | -0.40% | 80,600 | - |
| 412 | IBO | Impact BioMedical Inc. | 57.53M | -0.02% | 217,207 | 32.00K |
| 413 | ICCC | ImmuCell Corporation | 57.26M | -4.80% | 89 | 27.64M |
| 414 | OSTX | OS Therapies Incorporated | 54.93M | 0.65% | 431,157 | - |
| 415 | EDSA | Edesa Biotech, Inc. | 53.26M | -3.63% | 450,547 | - |
| 416 | RADX | Radiopharm Theranostics Limited | 53.23M | -1.01% | 10,222 | 10.86M |
| 417 | PSTV | Plus Therapeutics, Inc. | 52.66M | -3.25% | 2,366,565 | 5.26M |
| 418 | ESLA | Estrella Immunopharma, Inc. | 51.70M | 0.82% | 19,011 | - |
| 419 | RLYB | Rallybio Corporation | 51.63M | -2.20% | 35,252 | 674.00K |
| 420 | KZR | Kezar Life Sciences, Inc. | 51.56M | 0.28% | 16,660 | - |
| 421 | ACRV | Acrivon Therapeutics, Inc. | 50.96M | -0.92% | 255,162 | - |
| 422 | INKT | MiNK Therapeutics, Inc. | 49.08M | -6.48% | 98,558 | - |
| 423 | TELO | Telomir Pharmaceuticals, Inc. | 48.36M | -0.94% | 53,621 | - |
| 424 | NXTC | NextCure, Inc. | 47.82M | -1.25% | 31,533 | - |
| 425 | NTRB | Nutriband Inc. | 47.37M | -0.97% | 5,965 | 2.28M |
| 426 | OKUR | OnKure Therapeutics, Inc. | 46.47M | -2.83% | 57,442 | - |
| 427 | ATRA | Atara Biotherapeutics, Inc. | 46.04M | 2.49% | 185,289 | 151.93M |
| 428 | ALGS | Aligos Therapeutics, Inc. | 45.48M | -2.91% | 10,636 | 2.19M |
| 429 | LSTA | Lisata Therapeutics, Inc. | 44.20M | -0.38% | 41,314 | 1.07M |
| 430 | ATOS | Atossa Therapeutics, Inc. | 43.23M | 5.02% | 98,678 | - |
| 431 | LITS | Lite Strategy, Inc. | 43.09M | 1.28% | 102,516 | - |
| 432 | APLM | Apollomics, Inc. | 42.51M | -2.89% | 2,240 | 6.93M |
| 433 | VERU | Veru Inc. | 40.77M | 0.40% | 32,740 | 16.89M |
| 434 | SNSE | Sensei Biotherapeutics, Inc. | 40.22M | 8.22% | 89,286 | - |
| 435 | HOWL | Werewolf Therapeutics, Inc. | 39.96M | -1.71% | 130,443 | 1.14M |
| 436 | XLO | Xilio Therapeutics, Inc. | 38.93M | -1.85% | 1,055,536 | 31.80M |
| 437 | CRVO | CervoMed Inc. | 38.86M | -4.98% | 33,071 | 6.16M |
| 438 | CELU | Celularity Inc. | 38.64M | 4.69% | 85,393 | 40.58M |
| 439 | PTN | Palatin Technologies, Inc. | 38.46M | -2.76% | 6,076 | 8.96M |
| 440 | EVAX | Evaxion A/S | 35.86M | 11.11% | 51,261 | 7.53M |
| 441 | JSPR | Jasper Therapeutics, Inc. | 35.81M | -4.49% | 149,413 | - |
| 442 | TVRD | Tvardi Therapeutics, Inc. | 35.65M | 0.53% | 7,208 | - |
| 443 | INMB | INmune Bio Inc. | 35.36M | -6.34% | 158,195 | 50.00K |
| 444 | PDSB | PDS Biotechnology Corporation | 35.30M | -5.80% | 132,925 | - |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 35.25M | -4.24% | 29,131 | 90.00K |
| 446 | OTLK | Outlook Therapeutics, Inc. | 34.72M | -3.71% | 587,278 | 205.70K |
| 447 | RNTX | Rein Therapeutics Inc. | 34.04M | 2.78% | 101,724 | - |
| 448 | PLUR | Pluri Inc. | 33.67M | 0.30% | 3,320 | 1.34M |
| 449 | ABVC | ABVC BioPharma, Inc. | 32.86M | -6.34% | 44,747 | 797.92K |
| 450 | NBY | NovaBay Pharmaceuticals, Inc. | 31.61M | -4.72% | 116,248 | 10.30M |
| 451 | TPST | Tempest Therapeutics, Inc. | 31.55M | -2.50% | 45,744 | - |
| 452 | BCTX | BriaCell Therapeutics Corp. | 31.46M | -4.38% | 116,556 | - |
| 453 | CVM | CEL-SCI Corporation | 30.39M | 1.49% | 8,078 | - |
| 454 | RNXT | RenovoRx, Inc. | 29.97M | 2.85% | 96,281 | 928.00K |
| 455 | CUE | Cue Biopharma, Inc. | 29.88M | -5.63% | 1,676,710 | 7.10M |
| 456 | LTRN | Lantern Pharma Inc. | 29.08M | -3.70% | 20,104 | - |
| 457 | HYPD | Hyperion DeFi, Inc. | 29.01M | 2.22% | 246,549 | 345.32K |
| 458 | AEON | AEON Biopharma, Inc. | 28.59M | -2.59% | 43,618 | - |
| 459 | KYNB | Kyntra Bio, Inc. | 28.17M | -2.21% | 25,893 | 8.30M |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 28.05M | -4.11% | 50,592 | - |
| 461 | DYAI | Dyadic International, Inc. | 27.87M | -3.86% | 35,009 | 3.34M |
| 462 | TVGN | Tevogen Bio Holdings Inc. | 27.55M | -9.02% | 14,499 | - |
| 463 | IGC | IGC Pharma, Inc. | 27.19M | -2.34% | 150,052 | 1.11M |
| 464 | PASG | Passage Bio, Inc. | 26.59M | -2.01% | 30,566 | - |
| 465 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.57M | -1.61% | 35,610 | - |
| 466 | SNTI | Senti Biosciences, Inc. | 26.29M | -1.01% | 41,979 | - |
| 467 | XCUR | Exicure, Inc. | 26.13M | -0.73% | 1,883 | 500.00K |
| 468 | NNVC | NanoViricides, Inc. | 25.70M | 3.48% | 814,155 | - |
| 469 | BOLD | Boundless Bio, Inc. | 25.54M | -1.72% | 22,928 | - |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 24.85M | -2.74% | 21,372 | 14.99M |
| 471 | VTGN | Vistagen Therapeutics, Inc. | 24.35M | 2.83% | 220,341 | 789.00K |
| 472 | BRNS | Barinthus Biotherapeutics plc | 23.72M | -1.78% | 5,892 | 14.97M |
| 473 | MRKR | Marker Therapeutics, Inc. | 22.84M | - | 72,239 | 4.69M |
| 474 | FBLG | FibroBiologics, Inc. | 22.62M | -1.65% | 499,762 | - |
| 475 | SKYE | Skye Bioscience, Inc. | 22.46M | -2.87% | 234,904 | - |
| 476 | DARE | Daré Bioscience, Inc. | 21.21M | -1.03% | 21,520 | -57.13K |
| 477 | ALLR | Allarity Therapeutics, Inc. | 21.15M | 4.37% | 141,649 | - |
| 478 | PLRZ | Polyrizon Ltd. | 20.09M | -1.77% | 9,212 | - |
| 479 | GNTA | Genenta Science S.p.A. | 19.92M | -3.41% | 19,876 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 19.90M | -0.45% | 93,101 | 570.00K |
| 481 | LGVN | Longeveron Inc. | 19.78M | 14.09% | 5,461,689 | 1.44M |
| 482 | CTXR | Citius Pharmaceuticals, Inc. | 19.37M | -4.88% | 371,461 | 3.94M |
| 483 | KTTA | Pasithea Therapeutics Corp. | 19.27M | -1.58% | 31,416 | - |
| 484 | INAB | IN8bio, Inc. | 19.19M | -1.26% | 16,347 | - |
| 485 | INTS | Intensity Therapeutics, Inc. | 19.17M | -4.36% | 71,599 | - |
| 486 | HOTH | Hoth Therapeutics, Inc. | 18.77M | 6.14% | 1,054,980 | - |
| 487 | CVKD | Cadrenal Therapeutics, Inc. | 18.25M | 0.06% | 30,078 | - |
| 488 | TRAW | Traws Pharma, Inc. | 17.98M | 13.07% | 97,866 | 2.85M |
| 489 | IOBT | IO Biotech, Inc. | 17.54M | -2.48% | 959,594 | - |
| 490 | LEXX | Lexaria Bioscience Corp. | 16.43M | -7.30% | 65,412 | 522.00K |
| 491 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 15.77M | -3.91% | 69,917 | - |
| 492 | SER | Serina Therapeutics, Inc. | 15.75M | -2.67% | 27,140 | 116.00K |
| 493 | PHIO | Phio Pharmaceuticals Corp. | 14.75M | 0.79% | 270,852 | - |
| 494 | COCP | Cocrystal Pharma, Inc. | 14.06M | -0.97% | 27,311 | - |
| 495 | CRIS | Curis, Inc. | 13.91M | 0.55% | 47,929 | 11.65M |
| 496 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.81M | -3.42% | 7,819 | - |
| 497 | CLRB | Cellectar Biosciences, Inc. | 13.78M | 9.80% | 47,922 | - |
| 498 | JUNS | Jupiter Neurosciences, Inc. | 13.69M | -0.58% | 29,070 | - |
| 499 | BCAB | BioAtla, Inc. | 13.67M | -0.59% | 420,575 | 11.00M |
| 500 | BCDA | BioCardia, Inc. | 13.61M | -0.62% | 7,408 | 3.00K |
| 501 | GTBP | GT Biopharma, Inc. | 13.39M | -3.57% | 393,175 | - |
| 502 | OSRH | OSR Holdings, Inc. | 13.35M | 9.50% | 321,004 | -90.52K |
| 503 | KAPA | Kairos Pharma, Ltd. | 12.64M | -3.77% | 68,023 | - |
| 504 | NCEL | NewcelX Ltd. | 12.31M | -0.37% | 5,819 | - |
| 505 | SNGX | Soligenix, Inc. | 12.24M | -1.30% | 120,745 | 2.34K |
| 506 | AKTX | Akari Therapeutics, Plc | 12.06M | 2.07% | 34,325 | - |
| 507 | GDTC | CytoMed Therapeutics Limited | 11.89M | -1.90% | 3,123 | 573.19K |
| 508 | BLRX | BioLineRx Ltd. | 11.76M | 0.60% | 2,490 | 12.74M |
| 509 | CALC | CalciMedica, Inc. | 11.55M | 6.01% | 170,361 | - |
| 510 | ACXP | Acurx Pharmaceuticals, Inc. | 11.41M | -25.70% | 5,211,340 | - |
| 511 | LIMN | Liminatus Pharma, Inc. | 11.39M | -0.43% | 507,050 | - |
| 512 | CMMB | Chemomab Therapeutics Ltd. | 11.39M | -5.13% | 37,056 | - |
| 513 | IMNN | Imunon, Inc. | 10.54M | -0.33% | 9,561 | - |
| 514 | BIVI | BioVie Inc. | 10.33M | -2.84% | 20,372 | - |
| 515 | MBRX | Moleculin Biotech, Inc. | 9.82M | -1.97% | 69,956 | - |
| 516 | ICU | SeaStar Medical Holding Corporation | 9.66M | -3.25% | 48,334 | 881.00K |
| 517 | PHGE | BiomX Inc. | 9.57M | -3.73% | 81,208 | - |
| 518 | ITRM | Iterum Therapeutics plc | 8.94M | -1.05% | 333,761 | 390.00K |
| 519 | CLGN | CollPlant Biotechnologies Ltd. | 8.78M | -0.23% | 15,561 | 2.48M |
| 520 | RNAZ | TransCode Therapeutics, Inc. | 8.55M | -2.66% | 14,202 | - |
| 521 | CDIO | Cardio Diagnostics Holdings, Inc. | 8.52M | -2.00% | 130,453 | 15.78K |
| 522 | NCNA | NuCana plc | 8.32M | 2.56% | 35,546 | - |
| 523 | KALA | KALA BIO, Inc. | 8.25M | -19.98% | 16,460,580 | - |
| 524 | TOVX | Theriva Biologics, Inc. | 8.19M | -0.11% | 689,742 | - |
| 525 | ERNA | Ernexa Therapeutics Inc. | 8.14M | 3.02% | 594,485 | 1,000.00 |
| 526 | PULM | Pulmatrix, Inc. | 8.11M | 0.45% | 2,680 | 3.00K |
| 527 | BOLT | Bolt Biotherapeutics, Inc. | 8.10M | 2.18% | 4,052 | 5.20M |
| 528 | QNTM | Quantum BioPharma Ltd. | 8.06M | 19.05% | 2,762,821 | - |
| 529 | ALZN | Alzamend Neuro, Inc. | 7.99M | -3.67% | 29,721 | - |
| 530 | KPRX | Kiora Pharmaceuticals, Inc. | 7.85M | -1.38% | 1,985 | 20.00K |
| 531 | GRDX | GridAI Technologies Corp. | 7.55M | -1.97% | 14,529 | - |
| 532 | TCRT | Alaunos Therapeutics, Inc. | 7.50M | -3.17% | 11,859 | 6.00K |
| 533 | IMRN | Immuron Limited | 7.48M | 4.88% | 29,072 | 4.99M |
| 534 | PMCB | PharmaCyte Biotech, Inc. | 7.41M | 1.49% | 13,744 | - |
| 535 | MLEC | Moolec Science SA | 7.12M | -1.80% | 129,888 | 7.83M |
| 536 | MBIO | Mustang Bio, Inc. | 7.06M | -2.30% | 19,171 | - |
| 537 | CELZ | Creative Medical Technology Holdings, Inc. | 6.88M | - | 10,406 | 6.00K |
| 538 | ADXN | Addex Therapeutics Ltd | 6.72M | -2.18% | 18 | 198.82K |
| 539 | EVGN | Evogene Ltd. | 6.60M | 11.25% | 809,061 | 3.85M |
| 540 | APM | Aptorum Group Limited | 6.57M | 0.40% | 9,671 | - |
| 541 | XTLB | XTL Biopharmaceuticals Ltd. | 6.39M | -3.71% | 3,632 | 968.00K |
| 542 | BRTX | BioRestorative Therapies, Inc. | 6.38M | 6.97% | 3,181,413 | 383.40K |
| 543 | PCSA | Processa Pharmaceuticals, Inc. | 6.12M | -6.25% | 7,829 | - |
| 544 | XBIO | Xenetic Biosciences, Inc. | 6.00M | -0.38% | 17,282 | 2.86M |
| 545 | PPBT | Purple Biotech Ltd | 5.98M | -2.74% | 5,890 | - |
| 546 | SLXN | Silexion Therapeutics Corp | 5.80M | -1.36% | 13,249 | - |
| 547 | QNCX | Quince Therapeutics, Inc. | 5.71M | -5.62% | 13,015,720 | - |
| 548 | PBM | Psyence Biomedical Ltd. | 5.69M | -0.40% | 5,431 | - |
| 549 | ASBP | Aspire Biopharma Holdings, Inc. | 5.68M | -9.60% | 124,306 | 1.94K |
| 550 | CANF | Can-Fite BioPharma Ltd. | 5.40M | -5.43% | 45,002 | 560.00K |
| 551 | APRE | Aprea Therapeutics, Inc. | 5.40M | -1.98% | 22,642 | 488.24K |
| 552 | CYCN | Cyclerion Therapeutics, Inc. | 5.33M | -2.10% | 6,714 | 2.86M |
| 553 | MTVA | MetaVia Inc. | 5.13M | -1.84% | 52,174 | - |
| 554 | GOVX | GeoVax Labs, Inc. | 4.99M | 1.60% | 24,744 | 3.35M |
| 555 | VIVS | VivoSim Labs, Inc. | 4.88M | -3.61% | 40,885 | 142.00K |
| 556 | SILO | Silo Pharma, Inc. | 4.75M | -2.03% | 111,727 | 72.10K |
| 557 | APVO | Aptevo Therapeutics Inc. | 4.59M | 4.07% | 36,986 | - |
| 558 | LNAI | Lunai Bioworks Inc. | 4.58M | -0.47% | 25,002,522 | - |
| 559 | REVB | Revelation Biosciences, Inc. | 4.58M | -8.89% | 67,228 | - |
| 560 | BGMS | Bio Green Med Solution, Inc. | 4.50M | -0.22% | 7,651 | 81.00K |
| 561 | GNPX | Genprex, Inc. | 4.43M | -4.50% | 230,257 | - |
| 562 | OGEN | Oragenics, Inc. | 4.31M | 14.20% | 811,189 | - |
| 563 | GRI | GRI Bio, Inc. | 4.15M | -2.38% | 15,896 | - |
| 564 | GLMD | Galmed Pharmaceuticals Ltd. | 4.10M | -1.42% | 10,024 | - |
| 565 | DCOY | Decoy Therapeutics Inc. | 3.98M | -4.90% | 7,912 | - |
| 566 | INDP | Indaptus Therapeutics, Inc. | 3.93M | -0.31% | 5,639 | - |
| 567 | MTNB | Matinas BioPharma Holdings, Inc. | 3.91M | -4.36% | 11,205 | - |
| 568 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.33M | -19.57% | 4,349,683 | 1.36M |
| 569 | DRMA | Dermata Therapeutics, Inc. | 3.10M | -0.76% | 55,544 | - |
| 570 | XRTX | XORTX Therapeutics Inc. | 3.08M | -4.23% | 10,340 | - |
| 571 | AZTR | Azitra, Inc. | 3.07M | -0.94% | 615,786 | 7.50K |
| 572 | HCWB | HCW Biologics Inc. | 2.97M | -1.89% | 62,458 | 422.03K |
| 573 | ARTL | Artelo Biosciences, Inc. | 2.81M | -4.11% | 27,613 | - |
| 574 | ADIL | Adial Pharmaceuticals, Inc. | 2.68M | -4.57% | 24,764 | - |
| 575 | ENVB | Enveric Biosciences, Inc. | 2.65M | -3.30% | 14,217 | - |
| 576 | CDT | CDT Equity Inc. | 2.57M | 1.28% | 42,993 | - |
| 577 | SCNI | Scinai Immunotherapeutics Ltd. | 2.52M | -2.99% | 11,355 | 1.15M |
| 578 | CLDI | Calidi Biotherapeutics, Inc. | 2.48M | -2.75% | 121,137 | - |
| 579 | SPRC | SciSparc Ltd. | 2.47M | 13.51% | 3,212,219 | 1.31M |
| 580 | JAGX | Jaguar Health, Inc. | 2.44M | -4.96% | 248,925 | 11.79M |
| 581 | LYRA | Lyra Therapeutics, Inc. | 2.36M | 1.53% | 4,890 | 600.00K |
| 582 | ELAB | PMGC Holdings Inc. | 2.29M | -4.94% | 15,503 | 285.95K |
| 583 | BBLG | Bone Biologics Corporation | 2.26M | -1.52% | 1,083 | - |
| 584 | PPCB | Propanc Biopharma, Inc. | 2.04M | -7.93% | 3,742,966 | - |
| 585 | CNSP | CNS Pharmaceuticals, Inc. | 1.87M | 1.66% | 9,131 | - |
| 586 | CMND | Clearmind Medicine Inc. | 1.68M | -0.23% | 53,147 | - |
| 587 | ENSC | Ensysce Biosciences, Inc. | 1.57M | -5.52% | 181,942 | 4.49M |
| 588 | VRAX | Virax Biolabs Group Limited | 1.49M | -1.57% | 69,538 | 2.99K |
| 589 | ONCO | Onconetix, Inc. | 901.91K | -7.20% | 32,399 | 1.22M |
| 590 | BDRX | Biodexa Pharmaceuticals Plc | 746.52K | -2.63% | 20,408 | 104.90K |
| 591 | ADTX | Aditxt, Inc. | 570.55K | -3.93% | 30,065 | 5.95K |